⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19339603 | 0.82 | — | — | |
| SCHEMBL24261259 | 0.77 | TRPA1 (0.32) | — | |
| SCHEMBL4510359 | 0.71 | — | — | |
| SCHEMBL25586484 | 0.70 | — | — | |
| SCHEMBL20390825 | 0.69 | — | — | |
| SCHEMBL18910775 | 0.68 | — | — | |
| SCHEMBL25804905 | 0.68 | — | — | |
| SCHEMBL24520774 | 0.67 | — | — | |
| SCHEMBL24146582 | 0.65 | — | — | |
| SCHEMBL21155936 | 0.65 | DNM1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022198196-A1 | INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF | MAZE THERAPEUTICS, INC. (US) | 2022-09-22 | — | — | WO | disclosed |